Adult Dosing

Treatment of androgenic alopecia

• Aerosol foam: Apply 1/2 capful to scalp bid
• Males
• Solution: Apply 1 mL 2%/5% soln to scalp bid

• Females
• Solution: Apply 1 mL 2% soln to scalp bid

Pediatric Dosing

• Safety and effectiveness in pediatrics have not been established

[Outline]

• Adult Dosing
• Pediatric Dosing

• Treatment of androgenic alopecia

• Hypersensitivity to any of the ingredients of the product
• Red, inflamed, infected, irritated, or painful scalp
• <18 yrs of age

• N/A

Renal Dose Adjustments

• Renal impairment: Caution advised, dose adjustments not defined

Hepatic Dose Adjustments

• Hepatic impairment: Dose adjustments not defined

• It is for external use on scalp only, do not apply on other parts of the body
• Minoxidil is not intended to use for frontal baldness or receding hairline or hairless due to unknown reason
• Minoxidil can cause change in hair color and texture
• Minoxidil does not prevent or improve hair-loss due to medications, certain severe nutritional problems, hypothyroidism, chemotherapy, or diseases or damage due to use of haircare products scarring deep burns of the scalp
• The amount of hair growth is different in each person. It may take 2-4 months with twice a day usage to see the results
• Minoxidil can cause chest pain, rapid heartbeat, faintness or dizziness, discontinue the treatment if these symptoms occur
• Discontinue the treatment if scalp irritation or redness occurs
• Unwanted facial hair growth can occur with minoxidil use
• Discontinue the treatment if there is sudden unexplained weight gain or swelling of hand or feet

Cautions: Use cautiously in

• Severe renal impairment
• Heart diseases

Pregnancy Category:C

Breastfeeding: Less information available, caution should be exercised when using large doses. Low risk to breastfed infant when topical applied to nursing mother. This information is based upon LactMed database (available at http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?LACT last accessed 21 April 2011).

• CNS: Dizziness
• DERM: Skin irritation, pruritus, contact dermatitis
• CV: Chest pain, rapid heartbeat
• METABOLIC: Weight gain
• MISC: Swelling of hand and feet, unwanted facial hair growth

• Dermatological agent(vasodilator); exact mechanism is unknown, but likely is related to its arterial vasodilating action
• Metabolized by liver
• Renally excreted
• Half-life: 4.2 hrs

US Trade Name(s)

• Rogaine (For men)
• Rogaine (For Women)
• Men's rogaine
• Rogaine extra strength (For men)
• Theroxidil
• Women's rogaine

US Availability

minoxidil (generic)

• OTC SOLN: 2% (For Men)
• OTC SOLN: 2% (For Women)
• OTC SOLN: 5% (For Men)

Rogaine (For Men)

• OTC SOLN: 2%

Rogaine (For Women)

• OTC SOLN: 2%

Men's rogaine

• OTC Aerosol foam: 5%

Rogaine extra strength (For Men)

• OTC SOLN: 5%

Theroxidil

• OTC SOLN: 5%

Women's rogaine

• OTC Aerosol foam: 5%

Canadian Trade Name(s)

• Apo-gain liq
• Hair regrowth treatment
• Minox - liq top
• Rogaine

Canadian Availability

Apo-gain liq

• OTC LIQ: 20 mg/mL

Hair regrowth treatment

• OTC SOLN: 2%

Minox - liq top, Rogaine

• OTC SOLN: 20 mg/mL

UK Trade Name(s)

• Hair Loss Treatment Regular Strength
• Regaine for men extra strength
• Regaine for women regular strength
• Regaine for men extra strength scalp foam

UK Availability

minoxidil (generic)

• OTC SOLN: 2%

Hair Loss Treatment Regular Strength, Regaine for women regular strength

• OTC SOLN: 2%

Regaine for men extra strength

• OTC SOLN: 5%

Regaine for men extra strength scalp foam

• FOAM: 5%

Australian Trade Name(s)

• Hair A- Gain
• Rogaine for men regular strength
• Rogaine for women
• Rogaine for men extra strength

Australian Availability

Hair A- Gain

• LIQ: 50 mg/mL

Rogaine for men regular strength, Rogaine for women

• SOLN: 2%

Rogaine for men extra strength

• SOLN: 5%

[Outline]

Dermatologic

Peripheral Vasodilators

Dermatological Agents